Table 3 Impact of HPV 16/18 vaccine on abnormal cytology, diagnostic tests, and treated CIN lesions over the lifetime of a 12-year-old cohort in the United Kingdom

From: Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK

 

Abnormal cytology test a

Colposcopy

Biopsy

Treated CIN lesions

0% vaccine coverage

    
 

311 983

153 245

99 974

38 437

100% vaccine coverage

    
 

237 734

111 504

67 367

22 123

Reduction owing to vaccine

74 249

41 741

32 607

16 314

% Reduction

23.8%

27.2%

32.6%

42.4%

  1. aAbnormal cytology test includes those with borderline dyskaryosis or greater.
Back to article page